Who are Xenetic Biosciences, Inc.'s main suppliers?

Xenetic Biosciences, Inc. (XBIO) key suppliers include: SYNBIO, UVA, PHARMSYNTHEZ, PJSC-PHARMSYNTHEZ, SERUM-INSTITUTE-OF-INDIA and 1 more. View the full supplier network at chainsifter.com/chain/XBIO.

Who are Xenetic Biosciences, Inc.'s major customers?

Xenetic Biosciences, Inc. (XBIO) key customers include: TAKEDA-PHARMACEUTICALS-CO-LTD. View the full customer network at chainsifter.com/chain/XBIO.

What sector is Xenetic Biosciences, Inc. in?

Xenetic Biosciences, Inc. (XBIO) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

XBIO Supply Chain: Xenetic Biosciences, Inc. Supplier List & 9 Relationships

6Suppliers

1Customers

2Debt Items

0Related Chains

Xenetic Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
SYNBIO	SYNBIO	85%	The Company granted an exclusive license to SynBio to develop, market and commercialize certain drug candidates utilizing molecules based on SynBio’s technology and the Company’s proprietary technologies
UVA	UVA	85%	The Company paid UVA approximately $ 0.6 million under the UVA Agreement through March 31, 2026
PHARMSYNTHEZ	PHARMSYNTHEZ	80%	The Company granted an exclusive license to Pharmsynthez to develop, commercialize and market six product candidates based on the Company’s PolyXen and ImuXen technology in certain territories
PJSC-PHARMSYNTHEZ	PJSC-PHARMSYNTHEZ	80%	The Company has also entered into various research, development, license and supply agreements with PJSC Pharmsynthez
SERUM-INSTITUTE-OF-INDIA	SERUM-INSTITUTE-OF-INDIA	80%	The Company has also entered into various research, development, license and supply agreements with Serum Institute of India
SYNBIO-LLC	SYNBIO-LLC	80%	The Company has also entered into various research, development, license and supply agreements with SynBio LLC

Xenetic Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
TAKEDA-PHARMACEUTICALS-CO-LTD	TAKEDA-PHARMACEUTICALS-CO-LTD	92%	Royalty payments of approximately $ 0.8 million and $ 0.6 million were recorded as revenue during the three months ended March 31, 2026 and 2025, respectively, and are based on single digit royalties…

Xenetic Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
XBIO-DEBT-13639	Warrants outstanding: 29.09	90%	xbrl warrant detail from xbrl 2026-03-31.
XBIO-DEBT-13640	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2016-12-31.

Xenetic Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Xenetic Biosciences, Inc..

Xenetic Biosciences, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Xenetic Biosciences, Inc..

Xenetic Biosciences, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Xenetic Biosciences, Inc. Supply Chain